Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2021. Module: SNOMED CT core module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
4033009019 | Satralizumab (substance) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
4033010012 | Satralizumab | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Satralizumab | Is a | Immunosuppressant | true | Inferred relationship | Existential restriction modifier | ||
Satralizumab | Is a | Monoclonal antibody | true | Inferred relationship | Existential restriction modifier | ||
Satralizumab | Is a | Substance with interleukin 6 receptor antagonist mechanism of action (substance) | true | Inferred relationship | Existential restriction modifier | ||
Satralizumab | Has disposition | Interleukin 6 receptor antagonist | true | Inferred relationship | Existential restriction modifier |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Product containing satralizumab (medicinal product) | Has active ingredient | True | Satralizumab | Inferred relationship | Existential restriction modifier | 1 |
Product containing only satralizumab (medicinal product) | Has active ingredient | True | Satralizumab | Inferred relationship | Existential restriction modifier | 1 |
Product containing satralizumab in parenteral dose form (medicinal product form) | Has active ingredient | True | Satralizumab | Inferred relationship | Existential restriction modifier | 1 |
Product containing only satralizumab in parenteral dose form (medicinal product form) | Has active ingredient | True | Satralizumab | Inferred relationship | Existential restriction modifier | 1 |
This concept is not in any reference sets